RA
OM icon

Rise Advisors’s Outset Medical OM Stock Holding History

Rise Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$17 – 1186
2024
Q3 		$17 Hold
2
– – ﹤0.01% 1228
2024
Q2 		$96 Hold
2
– – ﹤0.01% 1231
2024
Q1 		$56 Hold
2
– – ﹤0.01% 1255
2023
Q4 		$135 Hold
2
– – ﹤0.01% 603
2023
Q3 		$272 Hold
2
– – ﹤0.01% 605
2023
Q2 		$547 Hold
2
– – ﹤0.01% 614
2023
Q1 		$460 Hold
2
– – ﹤0.01% 738
2022
Q4 		$646 Hold
2
– – ﹤0.01% 692
2022
Q3 		$0 Hold
2
– – ﹤0.01% 732
2022
Q2 		$0 Hold
2
– – ﹤0.01% 724
2022
Q1 		$1K Hold
2
– – ﹤0.01% 623
2021
Q4 		$1.15K Buy
+2
New +$1.48K ﹤0.01% 590

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rise Advisors's OM Position: Q4 2024 in Review

Rise Advisors sold out of Outset Medical (OM) in Q4 2024, closing a stake of 2 shares — an estimated $17 sold.

Rise Advisors first reported a position in OM in Q4 2021 and held it in 12 quarters. The position peaked at $1.15K in Q4 2021. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

  • Rise Advisors reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
  • Rise Advisors sold 2 Outset Medical shares in Q4 2024, an estimated $17.
  • Rise Advisors first reported a position in Outset Medical in Q4 2021 and held it in 12 quarters.
  • Rise Advisors's Outset Medical position peaked at $1.15K in Q4 2021.
  • 73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on Rise Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.